Silva Markovic‐Plese

5.1k total citations
68 papers, 4.1k citations indexed

About

Silva Markovic‐Plese is a scholar working on Immunology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Silva Markovic‐Plese has authored 68 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Immunology, 30 papers in Pathology and Forensic Medicine and 23 papers in Oncology. Recurrent topics in Silva Markovic‐Plese's work include Multiple Sclerosis Research Studies (30 papers), Immunotherapy and Immune Responses (26 papers) and T-cell and B-cell Immunology (20 papers). Silva Markovic‐Plese is often cited by papers focused on Multiple Sclerosis Research Studies (30 papers), Immunotherapy and Immune Responses (26 papers) and T-cell and B-cell Immunology (20 papers). Silva Markovic‐Plese collaborates with scholars based in United States, Germany and India. Silva Markovic‐Plese's co-authors include Xin Zhang, Henry F. McFarland, Roland Martinꝉ, Vinod S. Ramgolam, Jianping Jin, Yonggang Sha, Irene Cortese, Klaus‐Peter Wandinger, D A Hafler and J. Raus and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Investigation.

In The Last Decade

Silva Markovic‐Plese

68 papers receiving 4.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Silva Markovic‐Plese United States 33 2.3k 1.4k 797 757 556 68 4.1k
Mireia Sospedra Switzerland 33 2.8k 1.2× 1.7k 1.2× 943 1.2× 1.1k 1.5× 393 0.7× 74 5.0k
Vissia Viglietta United States 23 2.2k 0.9× 2.0k 1.5× 882 1.1× 662 0.9× 572 1.0× 65 4.5k
Nitin J. Karandikar United States 36 3.4k 1.5× 1.4k 1.0× 803 1.0× 1.0k 1.3× 291 0.5× 116 5.6k
Sawsan Youssef United States 30 2.4k 1.1× 954 0.7× 853 1.1× 1.4k 1.8× 663 1.2× 46 5.2k
Anthony Slavin United States 28 1.9k 0.8× 1.1k 0.8× 617 0.8× 986 1.3× 407 0.7× 53 3.6k
Bibiana Bielekova United States 38 3.1k 1.3× 2.9k 2.1× 1.0k 1.3× 1.1k 1.4× 756 1.4× 103 6.0k
Masaaki Niino Japan 30 1.3k 0.6× 1.7k 1.2× 426 0.5× 661 0.9× 493 0.9× 140 3.3k
Martin S. Weber Germany 41 2.6k 1.1× 2.6k 1.9× 875 1.1× 967 1.3× 640 1.2× 150 5.4k
Anna Schubart Switzerland 21 2.7k 1.2× 843 0.6× 1.1k 1.4× 1.2k 1.6× 183 0.3× 38 4.1k
Subramaniam Sriram United States 24 1.4k 0.6× 884 0.6× 407 0.5× 511 0.7× 270 0.5× 50 2.9k

Countries citing papers authored by Silva Markovic‐Plese

Since Specialization
Citations

This map shows the geographic impact of Silva Markovic‐Plese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silva Markovic‐Plese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silva Markovic‐Plese more than expected).

Fields of papers citing papers by Silva Markovic‐Plese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silva Markovic‐Plese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silva Markovic‐Plese. The network helps show where Silva Markovic‐Plese may publish in the future.

Co-authorship network of co-authors of Silva Markovic‐Plese

This figure shows the co-authorship network connecting the top 25 collaborators of Silva Markovic‐Plese. A scholar is included among the top collaborators of Silva Markovic‐Plese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silva Markovic‐Plese. Silva Markovic‐Plese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Freedman, Mark S., Patricia K. Coyle, Kerstin Hellwig, et al.. (2024). Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives. Neurology and Therapy. 13(2). 283–322. 4 indexed citations
2.
Wu, Bing, Yan Wang, Sahil Kapoor, et al.. (2022). Therapeutic Effect of Anti-CD52 Monoclonal Antibody in Multiple Sclerosis and Its Animal Models Is Mediated via T Regulatory Cells. The Journal of Immunology. 209(1). 49–56. 3 indexed citations
3.
Wu, Bing, Song Zhang, Zengli Guo, et al.. (2021). The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation. Immunity. 54(2). 308–323.e6. 71 indexed citations
4.
Zhang, Xin, Sahil Kapoor, Madhan Thamilarasan, et al.. (2019). IL-11 Induces Encephalitogenic Th17 Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis. The Journal of Immunology. 203(5). 1142–1150. 43 indexed citations
5.
Zhang, Xin, Sahil Kapoor, Stephanie M. Cohen, et al.. (2018). IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis. Clinical Immunology. 197. 45–53. 11 indexed citations
6.
Plummer, Prudence, et al.. (2016). Combining Dalfampridine with Physical Therapy May Improve Treatment Effects in Dalfampridine Non-responders with Multiple Sclerosis: A Case Study. Archives of Physical Medicine and Rehabilitation. 97(10). e62–e62. 1 indexed citations
7.
Markovic‐Plese, Silva, et al.. (2015). Immunomodulatory therapies for relapsing-remitting multiple sclerosis: monoclonal antibodies, currently approved and in testing. Expert Review of Clinical Pharmacology. 8(3). 283–296. 6 indexed citations
8.
9.
Zedek, Daniel C., et al.. (2014). Dermatomyositis as a presentation of neuromyelitis optica spectrum disorder. Journal of Neuroimmunology. 278. 108–111. 9 indexed citations
10.
Broux, Bieke, Xin Zhang, Silva Markovic‐Plese, et al.. (2011). CX3CR1 drives cytotoxic CD4+CD28− T cells into the brain of multiple sclerosis patients. Journal of Autoimmunity. 38(1). 10–19. 104 indexed citations
11.
Sha, Yonggang & Silva Markovic‐Plese. (2011). A role of IL-1R1 signaling in the differentiation of Th17 cells and the development of autoimmune diseases. PubMed. 2(1). 35–42. 39 indexed citations
12.
Zhang, Xin, et al.. (2009). IFN-β1a Inhibits the Secretion of Th17-Polarizing Cytokines in Human Dendritic Cells via TLR7 Up-Regulation. The Journal of Immunology. 182(6). 3928–3936. 80 indexed citations
13.
Ramgolam, Vinod S., Yonggang Sha, Jianping Jin, Xin Zhang, & Silva Markovic‐Plese. (2009). IFN-β Inhibits Human Th17 Cell Differentiation. The Journal of Immunology. 183(8). 5418–5427. 181 indexed citations
14.
Zhang, Xin, Laureline Berthelot, David Laplaud, et al.. (2008). Oligoclonal myelin-reactive T-cell infiltrates derived from multiple sclerosis lesions are enriched in Th17 cells. Clinical Immunology. 130(2). 133–144. 104 indexed citations
15.
Zhang, Xin, Jianping Jin, Xueyan Peng, Vinod S. Ramgolam, & Silva Markovic‐Plese. (2008). Simvastatin Inhibits IL-17 Secretion by Targeting Multiple IL-17-Regulatory Cytokines and by Inhibiting the Expression of IL-17 Transcription Factor RORC in CD4+ Lymphocytes. The Journal of Immunology. 180(10). 6988–6996. 162 indexed citations
16.
Zhang, Xin, Yunan Tang, Jinzhao Wang, et al.. (2008). Degenerate TCR recognition and dual DR2 restriction of autoreactive T cells: Implications for the initiation of the autoimmune response in multiple sclerosis. European Journal of Immunology. 38(5). 1297–1309. 18 indexed citations
17.
Markovic‐Plese, Silva, Bernhard Hemmer, Yingdong Zhao, et al.. (2005). High level of cross-reactivity in influenza virus hemagglutinin-specific CD4+ T-cell response: Implications for the initiation of autoimmune response in multiple sclerosis. Journal of Neuroimmunology. 169(1-2). 31–38. 39 indexed citations
18.
Zhao, Yingdong, Bruno Gran, Clemencia Pinilla, et al.. (2001). Combinatorial Peptide Libraries and Biometric Score Matrices Permit the Quantitative Analysis of Specific and Degenerate Interactions Between Clonotypic TCR and MHC Peptide Ligands. The Journal of Immunology. 167(4). 2130–2141. 79 indexed citations
19.
Markovic‐Plese, Silva & Henry F. McFarland. (2001). Immunopathogenesis of the multiple sclerosis lesion. Current Neurology and Neuroscience Reports. 1(3). 257–262. 67 indexed citations
20.
Markovic‐Plese, Silva, Hikoaki Fukaura, A AL-Sabbagh, et al.. (1995). T cell recognition of immunodominant and cryptic proteolipid protein epitopes in humans. The Journal of Immunology. 155(2). 982–992. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mireia Sospedra Breakdown of academic impact, for papers by Vissia Viglietta Breakdown of academic impact, for papers by Nitin J. Karandikar Breakdown of academic impact, for papers by Sawsan Youssef Breakdown of academic impact, for papers by Anthony Slavin Breakdown of academic impact, for papers by Bibiana Bielekova Breakdown of academic impact, for papers by Masaaki Niino Breakdown of academic impact, for papers by Martin S. Weber Breakdown of academic impact, for papers by Anna Schubart Breakdown of academic impact, for papers by Subramaniam Sriram
Rankless by CCL
2026